Want to join the conversation?
$SEE said that over the last 24 months, the company has consolidated 9% of its total facilities with another planned incremental reduction of 5% over the next 12-18 months. The company has reduced its total active SKUs by 30% since 2013 and expects to continue to optimize SKUs going forward.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.